Cancer Related Content

Ivan Stamenkovic, Professor of Experimental Pathology at University of Lausanne explores the paediatric sarcoma metastasis and why this warrants an in-depth look Metastasis is responsible for 90% of cancer–related death. Several solid paediatric malignancies, particularly sarcomas, display high metastatic proclivity, which renders their prognosis poor, as metastases are for the...

Prime Minister Theresa May has announced a further £75m in funding for “earlier and faster” diagnosis and treatment of prostate cancer, which kills more than 10,000 men each year

Europa Uomo – European Prostate Cancer Coalition Secretary, John Dowling shares his thoughts on the prostate gland, described as a most troublesome piece of tissue.

Researchers at the National Institutes of Health (NIH) have used genomics to set apart squamous cancer cells (SCC’s) from other cancers. This could improve treatments for head and neck cancers.

Eigil Kjeldsen from Aarhus University Hospital gives an expert perspective on the drive towards precision and targeted medicine for acute leukaemia

Bethany Torr, campaigns and advocacy officer at Leukaemia Care discusses the impact of chronic lymphocytic leukaemia (CLL) and acute myeloid leukaemia (AML) on patients

New research has found that the Zika virus could be an alternative for treatment of glioblastoma, the most common and aggressive kind of brain cancer in adults

The need for supportive care in oncology will increase as patients continue to live longer and cancer progresses to become more like a chronic disease Supportive care increases patient quality of life, improves their chances of completing treatment, can reduce costs for healthcare institutions, and is fundamentally necessary given that...

Professor Jatinder Lamba from the Department of Pharmacotherapy and Translational Research gives an in-depth perspective on acute myeloid leukaemia (AML) and cytarabine pharmacogenomics Acute myeloid leukaemia (AML) is the cancer of the myeloid precursor stem cells character­ised by the appearance of immature, abnormal myeloid cells in bone marrow and other...

Acute myeloid leukaemia (AML), a form of blood cancer is placed into the spotlight by Open Access Government Acute myeloid leukaemia (AML) is a form of blood cancer, which affects the white blood cells known as myeloid cells. It is a rapidly progressing form of leukaemia. Blood cells are formed...

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group highlights technology interventions that address dyspnoea – focussing on point-of-care lung ultrasonography The Murray and Nadel’s Textbook of Respiratory Medicine (Schwartzstein and Adams, 2016), etymologically defines dyspnoea from the Greek dys (painful, difficult) and pneuma (breath). Clinically, dyspnoea constitutes a medical...

Dr Miranda Fidler from the International Agency for Research on Cancer highlights the burden of cancer and the need for prevention, diagnosis, and care Cancer is a major cause of morbidity and mortality across all age groups in both developed and transitioning countries. Although substantial research on cancer in children...

CEO of Roy Castle Lung Cancer Foundation, Paula Chadwick, explains why it is now the time to finally prioritise lung health The events of Tuesday 21st November 2017 have the potential to change the lives of thousands of people in England. It was the day NHS England finally prioritised early...

All.Can shares their profound insights into the challenges concerning the need to improve the efficiency of cancer care, focusing on better outcomes for patients Healthcare budgets are under increasing pressure. We face an urgent question about how we can sustain high-quality healthcare. All.Can is an international multi-stakeholder initiative set up...

Experts from the Lymphoma Association offer their thoughts on the extent of lymphoma in the UK today and how treatment and diagnosis can improve Every 28 minutes someone is diagnosed with lymphoma. It is the fifth most common cancer in the UK with more than 19,000 people diagnosed every year,...

Professor Ruth Ladenstein from SIOPE (the European Society for Paediatric Oncology) discusses how ERN PaedCan facilitates effective cross-border healthcare The European Commission launched 24 different networks to bring together experts from across the EU to tackle rare diseases by improving diagnosis, treatment and access to specialist care. These are known...

This compelling article is written by Professor of Neurotoxicology, Pamela J. Lein, Ph.D. who is based at University of California’s Davis/School of Veterinary Medicine. The thrust of the article is that polychlorinated biphenyls (PCBs) are a continuing environmental health concern in today’s world Not shying away from detail, the piece...

Jonathan Miles from Open Access Government explored the work the Danish Ministry of Health does to improve health policy across the country The Danish Ministry of Health was officially established in June 2015 and is responsible for all healthcare policies in Denmark. Once an independent ministry when first launched in...

Bethany Torr, campaigns and advocacy officer at Leukaemia Care introduces ‘Leukaemia’ and its different forms and explains how people live with the disease Leukaemia’ is an umbrella term for cancers of the white blood cells – ‘leuk’ means white and ‘aemia’ refers to a condition of the blood. 26 people are...

Islam Elkonaissi and Zahra Laftah from the UKCPA explore the British model of supporting excellence in clinical pharmacy practice In the UK, evidence that pharmacists can provide better clinical outcomes and more efficient, consistent and sustainable services for patients, is increasing. In this article, key themes are discussed to showcase...